CLDX vs IDXX · rev $37.0K vs P/E 40, rev $2.36B
Celldex Therapeutics Inc (CLDX) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CLDX currently screens at market cap $2.35B. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CLDX and IDXX stock pages for the full models.
Not investment advice.